mRNA-1982

· ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for mRNA-1982, covering 2025-08-22 to 2026-07-30. Get the full timeline:

Most recent: Clinical Trial Results: A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age [Phase 1, Phase 2]

See pricing